Cardio-Oncology Practice Manual: A Companion to Braunwald's Heart Disease
Herausgeber: Herrmann, Joerg
Cardio-Oncology Practice Manual: A Companion to Braunwald's Heart Disease
Herausgeber: Herrmann, Joerg
- Broschiertes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Today's patients have unique cardiological needs before, during, and after cancer treatment. Chemotherapies, radiation therapy, and targeted therapies can produce side effects or lasting adverse consequences on the heart and circulatory system, making the field of cardio-oncology increasingly important in today's health care. Cardio-Oncology Practice Manual is a comprehensive, portable guide that provides practical approaches to assessment and management of cardiovascular disease due to the effects of cardiotoxic agents and treatments. Part of the Braunwald family of renowned cardiology…mehr
Andere Kunden interessierten sich auch für
- Daniel J. LenihanCardio-Oncology Related to Heart Failure, an Issue of Heart Failure Clinics105,99 €
- Morrow, David A, MD, MPH (Levine Cardiac Intensive Care Un DirectorMyocardial Infarction: A Companion to Braunwald's Heart Disease225,99 €
- Felker, G. Michael, MD, MHS, FACC, FAHA (Chie Professor of MedicineHeart Failure: A Companion to Braunwald's Heart Disease235,99 €
- Leonard S. Lilly (Cardiology Brigham Section Chief and Women's FauBraunwald's Heart Disease Review and Assessment85,99 €
- Leonard S. Lilly (CardiologyBrigham Section Chief and Women'sBraunwald's Heart Disease Review and Assessment88,99 €
- The Washington Manual of Cardio-Oncology73,99 €
- Zipes and Jalife's Cardiac Electrophysiology: From Cell to Bedside323,99 €
-
-
-
Today's patients have unique cardiological needs before, during, and after cancer treatment. Chemotherapies, radiation therapy, and targeted therapies can produce side effects or lasting adverse consequences on the heart and circulatory system, making the field of cardio-oncology increasingly important in today's health care. Cardio-Oncology Practice Manual is a comprehensive, portable guide that provides practical approaches to assessment and management of cardiovascular disease due to the effects of cardiotoxic agents and treatments. Part of the Braunwald family of renowned cardiology references, it clearly presents clinically-relevant aspects of this growing field in one quick, practical reference for a wide range of cardio-oncology providers.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Elsevier - Health Sciences Division
- Artikelnr. des Verlages: C2017-0-04254-4
- Seitenzahl: 544
- Erscheinungstermin: 7. März 2022
- Englisch
- Abmessung: 239mm x 193mm x 32mm
- Gewicht: 1100g
- ISBN-13: 9780323681353
- ISBN-10: 0323681352
- Artikelnr.: 62356104
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- 06621 890
- Verlag: Elsevier - Health Sciences Division
- Artikelnr. des Verlages: C2017-0-04254-4
- Seitenzahl: 544
- Erscheinungstermin: 7. März 2022
- Englisch
- Abmessung: 239mm x 193mm x 32mm
- Gewicht: 1100g
- ISBN-13: 9780323681353
- ISBN-10: 0323681352
- Artikelnr.: 62356104
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- 06621 890
1. The Cardio-Oncology Clinic
Part I. Cardiovascular Disease Management Before Cancer Treatment
Section A. The A-to-Z Before Therapy
2. Key Points of Cardio-Oncology Evaluation Before Cancer Therapy
3. Chemotherapeutic Risks Before Cancer Therapy
4. Radiation Therapy Risks Before Cancer Therapy
5. Bone Marrow Transplantation Risks Before Cancer Therapy
6. Surgical Risks Before Cancer Therapy
Section B. Cardiovascular Disease Prevention in Cancer Patients
7. Cardiomyopathy/Heart Failure Prevention Before Cancer Therapy
8. Vascular Disease Prevention Before Cancer Therapy
9. Thromboembolic Disease Prevention Before Cancer Therapy
10. Arrhythmia Prevention and Device Management Before Cancer Therapy
11. Hypertension and Renal Disease Prevention Before Cancer Therapy
12. Pulmonary Disease Prevention Before Cancer Therapy
13. Cardiopulmonary Exercise for Prevention Before Cancer Therapy
Part II. Cardiovascular Disease Management During Cancer Treatment
Section C. The A-to-Z Through Therapy
14. Key Points of Cardio-Oncology Evaluation During Cancer Therapy
15. Cardiomyopathy/Heart Failure Myocarditis, and Takotsubo's During Cancer
Therapy
16. Structural Heart Disease
17. Vascular Disease
18. Thromboembolic Disease
19. Arrhythmia, QTc Prolongation, and Device Management
20. Hypertension and Renal Disease
21. Pulmonary Disease
22. Cardiovascular Imaging
Part III. Cardiovascular Disease Management After Cancer Treatment
Section D. The A-to-Z After Therapy
23. Key Points of Cardio-Oncology Evaluation After Cancer Therapy
24. Cancer Survivorship and Co-Morbidity Disease Risk
25. Long-Term Complications of Chemotherapy
26. Long-Term Complications of Radiation Therapy
Section E. Cardiovascular Disease in Cancer Survivors
27. Cardiomyopathy/Heart Failure Prevention and Management
28. Structureal Heart Disease Prevention and Management
29. Vascular Disease Prevention and Management
30. Thromboembolic Disease Prevention and Manageent
31. Arrhythmia Prevention and Management
32. Hypertension and Renal Failure Prevention and Management
33. Pulmonary Disease Prevention and Management
34. Cardiopulmonary Rehabilitation
Section F. Cardiovascular Disease Management in Specific Malignant Diseases
35. Breast Cancer
36. Uterine, Ovary, and Cervical Cancer
37. Prostate and Testicular Cancer
38. Renal and Urinary Bladder Cancer
39. Lung Cancer
40. Colorectal Cancer
41. Esophageal and Gastric Cancer
42. Hepatobiliary Carcinomas
43. Pancreatic Cancer
44. Melanoma
45. Head-and-Neck Cancers
46. Thyroid cancer
47. Glioblastoma
48. Bone and Soft Tissue Sarcomas
49. Leukemias
50. Lymphomas
51. Multiple Myeloma and Cardiac Amyloidosis
52. Carcinoid
53. Cardiac Masses
Part IV. Cancer Drugs
54. Cancer Therapeutic Drug Guide
Part I. Cardiovascular Disease Management Before Cancer Treatment
Section A. The A-to-Z Before Therapy
2. Key Points of Cardio-Oncology Evaluation Before Cancer Therapy
3. Chemotherapeutic Risks Before Cancer Therapy
4. Radiation Therapy Risks Before Cancer Therapy
5. Bone Marrow Transplantation Risks Before Cancer Therapy
6. Surgical Risks Before Cancer Therapy
Section B. Cardiovascular Disease Prevention in Cancer Patients
7. Cardiomyopathy/Heart Failure Prevention Before Cancer Therapy
8. Vascular Disease Prevention Before Cancer Therapy
9. Thromboembolic Disease Prevention Before Cancer Therapy
10. Arrhythmia Prevention and Device Management Before Cancer Therapy
11. Hypertension and Renal Disease Prevention Before Cancer Therapy
12. Pulmonary Disease Prevention Before Cancer Therapy
13. Cardiopulmonary Exercise for Prevention Before Cancer Therapy
Part II. Cardiovascular Disease Management During Cancer Treatment
Section C. The A-to-Z Through Therapy
14. Key Points of Cardio-Oncology Evaluation During Cancer Therapy
15. Cardiomyopathy/Heart Failure Myocarditis, and Takotsubo's During Cancer
Therapy
16. Structural Heart Disease
17. Vascular Disease
18. Thromboembolic Disease
19. Arrhythmia, QTc Prolongation, and Device Management
20. Hypertension and Renal Disease
21. Pulmonary Disease
22. Cardiovascular Imaging
Part III. Cardiovascular Disease Management After Cancer Treatment
Section D. The A-to-Z After Therapy
23. Key Points of Cardio-Oncology Evaluation After Cancer Therapy
24. Cancer Survivorship and Co-Morbidity Disease Risk
25. Long-Term Complications of Chemotherapy
26. Long-Term Complications of Radiation Therapy
Section E. Cardiovascular Disease in Cancer Survivors
27. Cardiomyopathy/Heart Failure Prevention and Management
28. Structureal Heart Disease Prevention and Management
29. Vascular Disease Prevention and Management
30. Thromboembolic Disease Prevention and Manageent
31. Arrhythmia Prevention and Management
32. Hypertension and Renal Failure Prevention and Management
33. Pulmonary Disease Prevention and Management
34. Cardiopulmonary Rehabilitation
Section F. Cardiovascular Disease Management in Specific Malignant Diseases
35. Breast Cancer
36. Uterine, Ovary, and Cervical Cancer
37. Prostate and Testicular Cancer
38. Renal and Urinary Bladder Cancer
39. Lung Cancer
40. Colorectal Cancer
41. Esophageal and Gastric Cancer
42. Hepatobiliary Carcinomas
43. Pancreatic Cancer
44. Melanoma
45. Head-and-Neck Cancers
46. Thyroid cancer
47. Glioblastoma
48. Bone and Soft Tissue Sarcomas
49. Leukemias
50. Lymphomas
51. Multiple Myeloma and Cardiac Amyloidosis
52. Carcinoid
53. Cardiac Masses
Part IV. Cancer Drugs
54. Cancer Therapeutic Drug Guide
1. The Cardio-Oncology Clinic
Part I. Cardiovascular Disease Management Before Cancer Treatment
Section A. The A-to-Z Before Therapy
2. Key Points of Cardio-Oncology Evaluation Before Cancer Therapy
3. Chemotherapeutic Risks Before Cancer Therapy
4. Radiation Therapy Risks Before Cancer Therapy
5. Bone Marrow Transplantation Risks Before Cancer Therapy
6. Surgical Risks Before Cancer Therapy
Section B. Cardiovascular Disease Prevention in Cancer Patients
7. Cardiomyopathy/Heart Failure Prevention Before Cancer Therapy
8. Vascular Disease Prevention Before Cancer Therapy
9. Thromboembolic Disease Prevention Before Cancer Therapy
10. Arrhythmia Prevention and Device Management Before Cancer Therapy
11. Hypertension and Renal Disease Prevention Before Cancer Therapy
12. Pulmonary Disease Prevention Before Cancer Therapy
13. Cardiopulmonary Exercise for Prevention Before Cancer Therapy
Part II. Cardiovascular Disease Management During Cancer Treatment
Section C. The A-to-Z Through Therapy
14. Key Points of Cardio-Oncology Evaluation During Cancer Therapy
15. Cardiomyopathy/Heart Failure Myocarditis, and Takotsubo's During Cancer
Therapy
16. Structural Heart Disease
17. Vascular Disease
18. Thromboembolic Disease
19. Arrhythmia, QTc Prolongation, and Device Management
20. Hypertension and Renal Disease
21. Pulmonary Disease
22. Cardiovascular Imaging
Part III. Cardiovascular Disease Management After Cancer Treatment
Section D. The A-to-Z After Therapy
23. Key Points of Cardio-Oncology Evaluation After Cancer Therapy
24. Cancer Survivorship and Co-Morbidity Disease Risk
25. Long-Term Complications of Chemotherapy
26. Long-Term Complications of Radiation Therapy
Section E. Cardiovascular Disease in Cancer Survivors
27. Cardiomyopathy/Heart Failure Prevention and Management
28. Structureal Heart Disease Prevention and Management
29. Vascular Disease Prevention and Management
30. Thromboembolic Disease Prevention and Manageent
31. Arrhythmia Prevention and Management
32. Hypertension and Renal Failure Prevention and Management
33. Pulmonary Disease Prevention and Management
34. Cardiopulmonary Rehabilitation
Section F. Cardiovascular Disease Management in Specific Malignant Diseases
35. Breast Cancer
36. Uterine, Ovary, and Cervical Cancer
37. Prostate and Testicular Cancer
38. Renal and Urinary Bladder Cancer
39. Lung Cancer
40. Colorectal Cancer
41. Esophageal and Gastric Cancer
42. Hepatobiliary Carcinomas
43. Pancreatic Cancer
44. Melanoma
45. Head-and-Neck Cancers
46. Thyroid cancer
47. Glioblastoma
48. Bone and Soft Tissue Sarcomas
49. Leukemias
50. Lymphomas
51. Multiple Myeloma and Cardiac Amyloidosis
52. Carcinoid
53. Cardiac Masses
Part IV. Cancer Drugs
54. Cancer Therapeutic Drug Guide
Part I. Cardiovascular Disease Management Before Cancer Treatment
Section A. The A-to-Z Before Therapy
2. Key Points of Cardio-Oncology Evaluation Before Cancer Therapy
3. Chemotherapeutic Risks Before Cancer Therapy
4. Radiation Therapy Risks Before Cancer Therapy
5. Bone Marrow Transplantation Risks Before Cancer Therapy
6. Surgical Risks Before Cancer Therapy
Section B. Cardiovascular Disease Prevention in Cancer Patients
7. Cardiomyopathy/Heart Failure Prevention Before Cancer Therapy
8. Vascular Disease Prevention Before Cancer Therapy
9. Thromboembolic Disease Prevention Before Cancer Therapy
10. Arrhythmia Prevention and Device Management Before Cancer Therapy
11. Hypertension and Renal Disease Prevention Before Cancer Therapy
12. Pulmonary Disease Prevention Before Cancer Therapy
13. Cardiopulmonary Exercise for Prevention Before Cancer Therapy
Part II. Cardiovascular Disease Management During Cancer Treatment
Section C. The A-to-Z Through Therapy
14. Key Points of Cardio-Oncology Evaluation During Cancer Therapy
15. Cardiomyopathy/Heart Failure Myocarditis, and Takotsubo's During Cancer
Therapy
16. Structural Heart Disease
17. Vascular Disease
18. Thromboembolic Disease
19. Arrhythmia, QTc Prolongation, and Device Management
20. Hypertension and Renal Disease
21. Pulmonary Disease
22. Cardiovascular Imaging
Part III. Cardiovascular Disease Management After Cancer Treatment
Section D. The A-to-Z After Therapy
23. Key Points of Cardio-Oncology Evaluation After Cancer Therapy
24. Cancer Survivorship and Co-Morbidity Disease Risk
25. Long-Term Complications of Chemotherapy
26. Long-Term Complications of Radiation Therapy
Section E. Cardiovascular Disease in Cancer Survivors
27. Cardiomyopathy/Heart Failure Prevention and Management
28. Structureal Heart Disease Prevention and Management
29. Vascular Disease Prevention and Management
30. Thromboembolic Disease Prevention and Manageent
31. Arrhythmia Prevention and Management
32. Hypertension and Renal Failure Prevention and Management
33. Pulmonary Disease Prevention and Management
34. Cardiopulmonary Rehabilitation
Section F. Cardiovascular Disease Management in Specific Malignant Diseases
35. Breast Cancer
36. Uterine, Ovary, and Cervical Cancer
37. Prostate and Testicular Cancer
38. Renal and Urinary Bladder Cancer
39. Lung Cancer
40. Colorectal Cancer
41. Esophageal and Gastric Cancer
42. Hepatobiliary Carcinomas
43. Pancreatic Cancer
44. Melanoma
45. Head-and-Neck Cancers
46. Thyroid cancer
47. Glioblastoma
48. Bone and Soft Tissue Sarcomas
49. Leukemias
50. Lymphomas
51. Multiple Myeloma and Cardiac Amyloidosis
52. Carcinoid
53. Cardiac Masses
Part IV. Cancer Drugs
54. Cancer Therapeutic Drug Guide